Veterinary Medicines

KARIFLOX 25 mg/ml oral solution for calves

Authorised
  • Enrofloxacin
Download as PDF

Product identification

Medicine name:
KARIFLOX 25 mg/ml oral solution for calves
KARIFLOX 25 mg/ml SOLUCION ORAL PARA TERNEROS
Active substance:
  • Enrofloxacin
Target species:
  • Cattle
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Enrofloxacin
    25.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        11
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:
  • Container Material:High density polyethylene bottlesContainer Closure:Polyethylene screw capContainer Colour:WhiteContainer Volume: 5 litreDosing Device:For all containers a 20 ml measuring device of polypropylene is included.
  • Container Material:High density polyethylene bottlesContainer Closure:Polyethylene screw capContainer Colour:WhiteContainer Volume: 1 litreDosing Device:For all containers a 20 ml measuring device of polypropylene is included.
  • Container Material:High density polyethylene bottlesContainer Closure:Polyethylene screw capContainer Colour:WhiteContainer Volume: 500 mlDosing Device:For all containers a 20 ml measuring device of polypropylene is included.
  • Container Material:High density polyethylene bottlesContainer Closure:Polyethylene screw capContainer Colour:WhiteContainer Volume: 250 mlDosing Device:For all containers a 20 ml measuring device of polypropylene is included.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Karizoo S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Karizoo S.A.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 2029 ESP
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0217/002
Concerned member states:
  • France
  • Germany
  • Netherlands
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
Spanish (PDF)
Published on: 16/02/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 16/02/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 16/02/2023
Download